At the present time, ORIC has completed IND-enabling studies for its lead drug candidate, ORIC-101. We have not initiated any clinical trials in patients but anticipate filing an IND and recruiting the first patient in a Phase 1 clinical trial before the end of 2017.

Please visit for information regarding clinical trials that may be applicable to you or your family member.